| Reaction Details |
|---|
 | Report a problem with these data |
| Target | Glucagon-like peptide 1 receptor |
|---|
| Ligand | BDBM50266693 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | ChEMBL_2217116 (CHEMBL5130248) |
|---|
| EC50 | 0.057000±n/a nM |
|---|
| Citation |  Palani, A; Nawrocki, AR; Orvieto, F; Bianchi, E; Mandi?, E; Pessi, A; Huang, C; Deng, Q; Toussaint, N; Walsh, E; Reddy, V; Ashley, E; He, H; Mumick, S; Hawes, B; Marsh, D; Erion, M; Nargund, R; Carrington, PE Discovery of MK-1462: GLP-1 and Glucagon Receptor Dual Agonist for the Treatment of Obesity and Diabetes. ACS Med Chem Lett13:1248-1254 (2022) [PubMed] Article |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| Glucagon-like peptide 1 receptor |
|---|
| Name: | Glucagon-like peptide 1 receptor |
|---|
| Synonyms: | GLP-1 receptor | GLP-1-R | GLP-1R | GLP1R | GLP1R_HUMAN | Glucagon-like peptide 1 receptor | Glucagon-like peptide 1 receptor (GLP-1) |
|---|
| Type: | Enzyme |
|---|
| Mol. Mass.: | 53035.78 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | P43220 |
|---|
| Residue: | 463 |
|---|
| Sequence: | MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDL
FCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPW
RDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIH
LNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAAN
YYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRN
SNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLL
GTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERW
RLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS
|
|
|
|---|
| BDBM50266693 |
|---|
| n/a |
|---|
| Name | BDBM50266693 |
|---|
| Synonyms: | CHEBI:5391 | Glucagen Hypokit | Glucagon | Glucagon Emergency Kit | Glucagon Recombinant |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C153H225N43O49S |
|---|
| Mol. Mass. | 3482.747 |
|---|
| SMILES | n/a |
|---|
| Structure | 
|
|---|
Search and Browse
